EW:NYSE
Edwards Lifesciences Corp
$107.15
arrow_upward
+1.19%(+1.26) 1D
$106.50
arrow_downward
-0.61% (-0.65)bedtimeAfter hours
Closed: Nov 13, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$106.10
High
$107.69
Low
$106.01
Mkt. cap
61.61B
Avg. vol.
4.51M
Volume
3.82M
P/E ratio
60.75
52-wk high
$107.69
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
Open
$106.10
High
$107.69
Low
$106.01
Mkt. cap
61.61B
Avg. vol.
4.51M
Volume
3.82M
P/E ratio
60.75
52-wk high
$107.69
52-wk low
$74.66
EPS
$1.76
Beta
0.85
Shares outstanding
575.00M
No. of employees
16K
News stories
From web sources and news partners
Traders Union
·
7 hours ago
MarketWise: Edwards Lifesciences revenue climbs 10.5 percent, earnings surge 19 percent
Trefis
·
20 hours ago
Is There Any Reason To Invest In Edwards Lifesciences Stock?
Zacks
·
1 day ago
Top Stock Reports for Visa, ExxonMobil & Pfizer
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorHealth Care
IndustryMedical device
Websiteedwards.com